SVNT

Sobi and Savient Pharmaceuticals Announce Co-Promotion Agreement for Kineret® (anakinra) in the U.S.

[at noodls] – More news 2013-02-19 Sobi Press Release on February 19, 2013, in PDF format CONTACT: Swedish Orphan Biovitrum (Sobi) AB Alan Raffensperger Chief Operating Officer +46 8 697 20 90 Savient Pharmaceuticals, … moreView todays social media effects on SVNTView the latest stocks trending across Twitter. Click to view dashboardSee who Savient is hiring next, click here to […]